Gene expression profile of peripheral blood mononuclear cells in response to HIV-VLPs stimulation

BackgroundBaculovirus-expressed HIV-1 Pr55gag Virus-Like Particles (HIV-VLPs) induce maturation and activation of monocyte-derived dendritic cells (MDDCs) with a production of Th1- and Th2-specific cytokines.ResultsThe analysis of genomic transcriptional profile of MDDCs, obtained from normal healthy donors and activated by HIV-VLPs, show the modulation of genes involved in the morphological and functional changes characterizing the MDDCs activation and maturation. Similar data are obtained using peripheral blood mononuclear cells (PBMCs), without further selection, showing the feasibility of a direct and “simplified” experimental procedure.ConclusionsThe results here described show that the maturation pattern induced by HIV-VLPs in ex vivo generated MDDCs, can be observed also in CD14-expressing freshly derived PBMCs, with the possible identification of genetic predictors of individual response to immunogens.

[1]  C. Leclerc,et al.  In Vivo, Dendritic Cells Can Cross-Present Virus-Like Particles Using an Endosome-to-Cytosol Pathway 1 , 2003, The Journal of Immunology.

[2]  S. Miltenyi,et al.  BDCA-2, BDCA-3, and BDCA-4: Three Markers for Distinct Subsets of Dendritic Cells in Human Peripheral Blood , 2000, The Journal of Immunology.

[3]  Yingdong Zhao,et al.  Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. , 2002, Cancer research.

[4]  Özlem Türeci,et al.  Cascades of transcriptional induction during dendritic cell maturation revealed by genome‐wide expression analysis , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  A. Lanzavecchia,et al.  Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation , 1996, The Journal of experimental medicine.

[6]  H. Pinedo,et al.  A CD34+ human cell line model of myeloid dendritic cell differentiation: evidence for a CD14+CD11b+ Langerhans cell precursor , 2006, Journal of leukocyte biology.

[7]  P. Roy,et al.  Virus-like particles as immunogens. , 2003, Trends in microbiology.

[8]  F. Marincola,et al.  Polarized monocyte response to cytokine stimulation , 2005, Genome Biology.

[9]  R. Verdijk,et al.  Polyriboinosinic polyribocytidylic acid (poly(I:C)) induces stable maturation of functionally active human dendritic cells. , 1999, Journal of immunology.

[10]  F. Marincola,et al.  Immature monocyte derived dendritic cells gene expression profile in response to Virus-Like Particles stimulation , 2005, Journal of Translational Medicine.

[11]  J. Davoust,et al.  ER–phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells , 2003, Nature.

[12]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[13]  P. Corti,et al.  Heteroduplex mobility assay and phylogenetic analysis of V3 region sequences of human immunodeficiency virus type 1 isolates from Gulu, northern Uganda. The Italian-Ugandan Cooperation AIDS Program , 1995, Journal of virology.

[14]  Y. Sakaki,et al.  A novel human CC chemokine PARC that is most homologous to macrophage-inflammatory protein-1 alpha/LD78 alpha and chemotactic for T lymphocytes, but not for monocytes. , 1997, Journal of immunology.

[15]  R. Tampé,et al.  Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[16]  M. Klemsz,et al.  Isolation and characterization of Exodus-2, a novel C-C chemokine with a unique 37-amino acid carboxyl-terminal extension. , 1997, Journal of immunology.

[17]  F. Marincola,et al.  High-fidelity mRNA amplification for gene profiling , 2000, Nature Biotechnology.

[18]  M. Foti,et al.  Coordinated events during bacteria-induced DC maturation. , 1999, Immunology today.

[19]  R. Vabulas,et al.  Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells , 1998, European journal of immunology.

[20]  G. Belz,et al.  Cross‐presentation, dendritic cell subsets, and the generation of immunity to cellular antigens , 2004, Immunological reviews.

[21]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Hanno Langen,et al.  Maturation, Activation, and Protection of Dendritic Cells Induced by Double-stranded RNA , 1999, The Journal of experimental medicine.

[23]  N. Chiorazzi,et al.  The global transcriptional maturation program and stimuli-specific gene expression profiles of human myeloid dendritic cells. , 2003, International immunology.

[24]  T. Mcclanahan,et al.  Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3alpha and MIP-3beta. , 1997, Journal of immunology.

[25]  F. Sallusto,et al.  Kinetics of dendritic cell activation: impact on priming of TH1, TH2 and nonpolarized T cells , 2000, Nature Immunology.

[26]  W. Heath,et al.  Cross-presentation in viral immunity and self-tolerance , 2001, Nature Reviews Immunology.

[27]  R. Steinman,et al.  Dendritic cells and the control of immunity , 1998, Nature.

[28]  E. Jacobs,et al.  Assembly and release of HIV-1 precursor Pr55 gag virus-like particles from recombinant baculovirus-infected insect cells , 1989, Cell.

[29]  T. Schall.  Biology of the RANTES/SIS cytokine family. , 1991, Cytokine.

[30]  F. Buonaguro,et al.  Induction of Systemic and Mucosal Cross-Clade Neutralizing Antibodies in BALB/c Mice Immunized with Human Immunodeficiency Virus Type 1 Clade A Virus-Like Particles Administered by Different Routes of Inoculation , 2005, Journal of Virology.

[31]  Christian A. Rees,et al.  Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.

[32]  M. Prevost,et al.  High efficient production of Pr55(gag) virus-like particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A. , 2001, Antiviral research.

[33]  L. Moldawer,et al.  Macrophages secrete a novel heparin-binding protein with inflammatory and neutrophil chemokinetic properties , 1988, The Journal of experimental medicine.

[34]  F. Sallusto,et al.  Understanding dendritic cell and T‐lymphocyte traffic through the analysis of chemokine receptor expression , 2000, Immunological reviews.

[35]  Joshua M. Korn,et al.  The plasticity of dendritic cell responses to pathogens and their components. , 2001, Science.

[36]  F. Buonaguro,et al.  A novel glycoprotein 120 sequence from an HIV type 1 isolate of the A clade identified in North Uganda. , 1998, AIDS research and human retroviruses.

[37]  L. Racioppi,et al.  Induction of neutralizing antibodies and cytotoxic T lymphocytes in Balb/c mice immunized with virus-like particles presenting a gp120 molecule from a HIV-1 isolate of clade A. , 2002, Antiviral research.

[38]  F. Buonaguro,et al.  Baculovirus-Derived Human Immunodeficiency Virus Type 1 Virus-Like Particles Activate Dendritic Cells and Induce Ex Vivo T-Cell Responses , 2006, Journal of Virology.